20th Annual Current Perspectives in Oncology Nursing
Conference has been rescheduled to February 2, 2023
Thursday, February 2, 2023
8 a.m. - 4:30 p.m.
University of South Florida Marshall Student Center
4103 USF Cedar Circle
Tampa, FL 33620
Registration Fees:
Moffitt Team Members – FREE!
Non-Moffitt attendees - $99
Exhibit opportunities available | Exhibit Letter | Exhibit Prospectus | Moffitt's W9
* Please refer to the conference website for full information regarding payments, parking and contact information.*
18th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
Saturday, January 28, 2023
Disney's Yacht Club Resort
1700 Epcot Resorts Blvd, Lake Buena Vista, FL 32830
View PDF presentations from the conference below:
Lymphoid Malignancies:
- Julio Chavez, MD - State of the Art: The Role of Bispecific Antibodies in the Management of B cell Lymphomas
- Hayder Saeed, MD - Treatment of Relapsed/Refractory Diffuse Large B cell Lymphomas
- Sameh Gaballa, MD - Debate: Choosing the Best Option for Relapsed/Refractory Follicular Lymphoma: Pro Conventional
- Michael Jain, MD - Debate: Choosing the Best Option for Relapsed/Refractory Follicular Lymphoma: Pro: Car T
Myeloid Malignancies:
- Alison Walker, MD, MPH - State of the Art: Best Practices for Managing AML in the Older Patient
- Andrew Kuykendall, MD - Navigating the Difficult Therapeutic Landscape of Myelofibrosis
- Eric Padron, MD - Debate: Early or Late Initiation of Treatment for MDS: Early
- David Sallman, MD - Debate: Early or Late Initiation of Treatment for MDS: Late
Mutiple Myeloma:
- Brandon Blue, MD - State of the Art Management of Precursor States - Present and Future
- Ariel Grajales-Cruz, MD - Management of Patients with Early Relapsed Multiple Myeloma
- Kenneth Shain, MD, PhD - Debate: Antibodies vs CAR T for Relapsed Refractory Myeloma: Bispecifics
- Omar Castaneda, MD - Debate: Antibodies vs CAR T for Relapsed Refractory Myeloma: CAR T
Hot off the Press!
- Kendra Sweet, MD - Myeloid Diseases
- Javier Pinilla, MD - Lymphoid Diseases
- Rachid Baz, MD - Plasma Cell Disease
